SAN FRANCISCO, Jan. 7, 2020 /PRNewswire/ -- TherapeuticsMD, Inc.
(NASDAQ: TXMD), an innovative women's healthcare company,
and PlushCare, a virtual health platform that enables patients to
book a virtual doctor's appointment to get treatment, today
announced that TherapeuticsMD's women's health products can be
prescribed to patients via the PlushCare platform.
"We are excited that women have an option to receive care via
the PlushCare virtual care platform, which provides a convenient
alternative for women to connect and talk to a doctor about
menopausal and reproductive treatment options," said TherapeuticsMD
Chief Commercial Officer Dawn
Halkuff.
"Oftentimes women's health problems can be easily dismissed or
overlooked, and now with companies like TherapeuticsMD, women's
health is being taken more seriously. We are extremely proud and
excited to offer access to products like TherapeuticsMD's as we are
continuously working to meet the demands of our patients," said
PlushCare co-founder and CEO, Ryan
McQuaid.
PlushCare is a virtual health platform offering affordable
primary care medical services to patients in all 50 U.S. states.
Having treated over 100,000 patients and diagnosed over 3,500
medical conditions, PlushCare is changing the medical landscape and
offering affordable and accessible healthcare to all.
For more information on PlushCare or TherapeuticsMD, please
visit Plushcare.com or TherapeuticsMD.com.
About PlushCare:
PlushCare is a virtual health
platform that offers primary healthcare and virtual doctor's visits
to patients in all 50 U.S. states. With over 100,000 users and
counting, patients are connected to physicians from the top 50
medical institutions in the country via desktop or mobile devices.
PlushCare accepts most major insurance plans, and patients have
access to quality primary care consultations and can get diagnosed,
treated, prescribed medication or have lab testing. The PlushCare
platform for virtual health provides a unique combination of
doctors, on-demand lab testing, affordable pricing, and same-day
appointments with the patient's choice of provider. Treating over
3,500 medical conditions, PlushCare strives to make patient's
healthcare experience with doctors stress-free and is available on
the PlushCare mobile app for iOS and Android or via
PlushCare.com.
About TherapeuticsMD, Inc.
TherapeuticsMD,
Inc. is an innovative, leading healthcare company, focused on
developing and commercializing novel products exclusively for
women. Our products are designed to address the unique changes and
challenges women experience through the various stages of their
lives with a therapeutic focus in family planning, reproductive
health, and menopause management. The company is committed to
advancing the health of women and championing awareness of their
healthcare issues. To learn more about TherapeuticsMD, please visit
www.therapeuticsmd.com or follow us on Twitter:
@TherapeuticsMD and on Facebook: TherapeuticsMD.
Forward-Looking Statements
This press release
by TherapeuticsMD, Inc. may contain forward-looking
statements. Forward-looking statements may include, but are not
limited to, statements relating to TherapeuticsMD's objectives,
plans and strategies as well as statements, other than historical
facts, that address activities, events or developments that the
company intends, expects, projects, believes or anticipates will or
may occur in the future. These statements are often characterized
by terminology such as "believes," "hopes," "may," "anticipates,"
"should," "intends," "plans," "will," "expects," "estimates,"
"projects," "positioned," "strategy" and similar expressions and
are based on assumptions and assessments made in light of
management's experience and perception of historical trends,
current conditions, expected future developments and other factors
believed to be appropriate. Forward-looking statements in this
press release are made as of the date of this press release, and
the company undertakes no duty to update or revise any such
statements, whether as a result of new information, future events
or otherwise. Forward-looking statements are not guarantees of
future performance and are subject to risks and uncertainties, many
of which are outside of the company's control. Important factors
that could cause actual results, developments and business
decisions to differ materially from forward-looking statements are
described in the sections titled "Risk Factors" in the company's
filings with the Securities and Exchange Commission, including
its most recent Annual Report on Form 10-K and Quarterly Reports on
Form 10-Q, as well as reports on Form 8-K, and include the
following: the company's ability to maintain or increase sales of
its products; the company's ability to develop and commercialize
IMVEXXYÒ, ANNOVERA™, BIJUVAÒ and
its hormone therapy drug candidates and obtain additional financing
necessary therefor; whether the company will be able to comply with
the covenants and conditions under its term loan facility,
including the conditions to draw additional tranches thereunder;
the potential of adverse side effects or other safety risks that
could adversely affect the commercialization of the company's
current or future approved products or preclude the approval of the
company's future drug candidates; the length, cost and uncertain
results of future clinical trials; the company's reliance on third
parties to conduct its manufacturing, research and development and
clinical trials; the ability of the company's licensees to
commercialize and distribute the company's products; the
availability of reimbursement from government authorities and
health insurance companies for the company's products; the impact
of product liability lawsuits; the influence of extensive and
costly government regulation; the volatility of the trading price
of the company's common stock and the concentration of power in its
stock ownership. PDF copies of the company's historical press
releases and financial tables can be viewed and downloaded at its
website: www.therapeuticsmd.com/pressreleases.aspx.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/therapeuticsmd-an-innovative-womens-healthcare-company-and-plushcare-a-virtual-health-platform-announce-enhanced-access-to-womens-health-products-300982053.html
SOURCE PlushCare